Dose of bupivacaine needed for pain relief in labor with lidocaine test dose
Official title: ED90 of Epidural Bupivacaine for the Initiation of Labor Analgesia: A Randomized Biased Coin Sequential Allocation Trial With a Lidocaine Test Dose
Run by Brigham and Women's Hospital · NCT05543694 · Data updated 2026-11-12
This trial tests the amount of bupivacaine needed to give initial comfortable pain relief for laboring women who receive a lidocaine test dose before an epidural.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | July 13, 2026 |
| Trial ID | NCT05543694 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women at term (37–42 weeks) undergoing labor with planned epidural analgesia, without major comorbidities and who request analgesia, with pain score of 5 or higher at the time of epidural request.
✕Probably not a fit
Women not receiving an epidural or those with contraindications to neuraxial analgesia may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional Phase 4 study uses a biased-coin up-down method to estimate the ED90 dose of bupivacaine for epidural analgesia during labor, comparing dural puncture epidural (DPE) and epidural plus local infiltration (EPL) techniques in women undergoing labor with induction or augmentation. Participants receive a lidocaine test dose per standard practice before epidural analgesia. Primary outcome is the dose of bupivacaine achieving initial comfort in 90% of patients with adequate precision. The study is conducted at Brigham and Women's Hospital, with no listed collaborators. Safety monitoring and standard obstetric analgesia protocols will be followed.
Why it matters
Potential benefit: If successful, the study could define precise bupivacaine dosing guidelines to reliably achieve early pain relief during labor.
How similar studies have gone: Previous work in neuraxial analgesia has used dose-tinding methods; this study applies a specific up-down allocation to estimate ED90 for this context, with mixed technique comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parturient with no major co-morbidities * Singleton, vertex gestation at term (37-42 weeks) * Less than or equal to 5 cm dilation * Desire to receive epidural labor analgesia * Numerical Rating Scale greater or equal to 5 (NRS 0-10, where 0 = no pain, and 10 = worst pain imaginable), at time of epidural labor analgesia request. Exclusion Criteria: * Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes) * Any contraindication to the administration of an epidural technique * History of hypersensitivity or idiosyncratic reaction to an amide local anesthetic agent * Current or historical evidence of a disease which may result in the risk of a cesarean delivery (i.e. history of uterine rupture). NB: Exception-trial of labor after cesarean delivery (TOLAC) will be eligible. * Evidence of anticipated fetal anomalies
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Lawrence C Tsen, MD
- Email: ltsen@bwh.harvard.edu
- Phone: 617-732-8216
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Three nerve blocks for knee replacement: which one works best
This trial tests three different nerve blocks used during knee replacement to see which provides the best pain relief for patients after surgery.
-
Rectointercostal plane block to reduce pain after laparoscopic gallbladder removal
This study tests whether giving a rectointercostal block during laparoscopic cholecystectomy can lower postoperative pain for patients without changing general anesthesia.
-
Dural Puncture Epidural (DPE) Technique in Labor Analgesia
This observational study at Ohio State tests whether the DPE method can reliably reveal CSF and improve epidural placement during labor without injecting medication.
-
STIL block versus RIB with sub-serratus plane block for pain relief after pediatric chest surgery
This study tests whether the STIL plane block provides comparable or better pain relief than the combination of RIB and sub-serratus plane block in children after thoracotomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.